Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Explore essential resources for zero based budgeting to help you manage your finances better. Start planning your budget effectively.
19,172 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
A new AI-driven marketing platform is entering the market via a Reg A+ offering at $0.85 a share, aiming to mirror th...
Lilly shares moved lower after Novo Nordisk announced price cuts on leading obesity drugs, signaling a tougher compet...
Signet Jewelers has shown momentum, but timing the entry is tricky. This guide breaks down fundamentals, market dynam...
Vistance (VISN) reports for 2025 show meaningful progress in revenue and margins, but the real story is how the compa...
Flux, a hardware-software startup, raised $37 million in a round led by 8VC to accelerate a browser-based electronics...
Space infrastructure hurdles are shrinking as Redwire reports stronger backlog and new contracts. This week, redwire ...
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
Oil-price volatility and strong cash-flow signals helped Occidental Petroleum stock jumped on Monday. Learn the drive...
A major fund exit and shifting industry dynamics pushed acadia healthcare stock tanked into focus. This guide breaks ...
March is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...
NVIDIA signals a potential shift in its OpenAI investment with new discussions about winding down the stake. The news...